Earnings History Data for MorphoSys (MOR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

MorphoSys

MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company's proprietary portfolio consists of MOR208, MOR202, MOR103, MOR106 and MOR107. Its partnered programs lighthouse project includes Tremfya(R) and Gantenerumab. MorphoSys AG is based in Planegg, Germany.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-04-2024	AH		MOR	MorphoSys	2,731	-2.24	-0.51	0.00	MorphoSys reports Q1 results [4/29/2024 4:55 PM]	17.41	0.05 (0.26%)	17.65	0.29 (1.67%)	4.18 - 18.31	1,044,714	740,000	217,554
MorphoSys reports Q1 results [4/29/2024 4:55 PM] New safety risk for MorphoSys drug could complicate Novartis deal - STAT (update) [4/29/2024 7:06 AM]
13-03-2024	AH		MOR	MorphoSys AG	2,450	0.33	-1.06	2.28	MorphoSys GAAP EPS of €1.22, revenue of €59M [3/13/2024 4:25 PM]	17.83	-0.21 (-1.16%)	18.00	-0.04 (-0.22%)	3.65 - 18.31	407,121	320,000	1,165
MorphoSys GAAP EPS of €1.22, revenue of €59M [3/13/2024 4:25 PM]
03-05-2023	AH	4:00 PM ET (May 3)	MOR	MorphoSys AG	731.15	-0.35	0.00	-1.01	MorphoSys GAAP EPS of -€1.30, revenue of €62.3M; reaffirms FY22 guidance [5/3/2023 5:37 PM]	5.50	0.35 (6.80%)	4.96	-0.26 (-4.98%)	3.17 - 6.15	183,592	70,000	260
MorphoSys GAAP EPS of -€1.30, revenue of €62.3M; reaffirms FY22 guidance [5/3/2023 5:37 PM]
15-03-2023	AH	4:00 PM ET (Mar 15)	MOR	MorphoSys AG	617.62	2.28	0.00	-3.30	MorphoSys GAAP EPS of €8.93, revenue of €81.6M [3/15/2023 4:20 PM]	4.01	0.27 (7.22%)	0.0	0.0 (0.00%)	3.17 - 7.45	192,523	80,000	0
MorphoSys GAAP EPS of €8.93, revenue of €81.6M [3/15/2023 4:20 PM]
16-11-2022	AH	4:00 PM ET (Nov 16)	MOR	MorphoSys AG	538.26	-0.91	0.00	-0.97	MorphoSys GAAP EPS of -€3.60, revenue of €95.8M [11/16/2022 4:07 PM]	3.98	0.12 (3.11%)	3.93	0.07 (1.81%)	3.70 - 10.84	40,932	190,000	4,976
MorphoSys GAAP EPS of -€3.60, revenue of €95.8M [11/16/2022 4:07 PM] MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results [Nov-16-22 04:01PM]
03-08-2022	AH	4:00 PM ET (Aug 3)	MOR	MorphoSys AG	740.35	-1.83	0.00	0.18	MorphoSys GAAP EPS of -€10.47, revenue of €100.9M [8/3/2022 4:19 PM]	5.67	-0.13 (-2.18%)	3.92	-0.40 (-9.26%)	4.35 - 15.16	12,109	20,000	51,552
MorphoSys GAAP EPS of -€10.47, revenue of €100.9M [8/3/2022 4:19 PM] MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results [Aug-03-22 04:01PM]
04-05-2022	AH	4:05 PM ET (May 4)	MOR	MorphoSys AG	737.61	-1.01	0.00	-0.38	MorphoSys GAAP EPS of -€3.59, revenue of €41.5M [5/4/2022 5:47 PM]	5.13	-0.28 (-5.18%)	5.32	0.0 (0.00%)	4.66 - 22.54	199,982	60,000	0
MorphoSys GAAP EPS of -€3.59, revenue of €41.5M [5/4/2022 5:47 PM] MorphoSys AG Reports First Quarter 2022 Financial Results [May-04-22 04:01PM]
16-03-2022	AH		MOR	MorphoSys AG	887.67	-3.30	0.00	-0.15		6.80	0.04 (0.59%)	6.38	0.06 (0.95%)	5.76 - 24.19	34,845	73,280	4,066
MorphoSys reports FY results [3/16/2022 4:20 PM] National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in Its Clinical Practice Guidelines in Oncology for B-cell Lymphomas [Mar-15-22 04:40PM] MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-16-22 04:07PM]
10-11-2021	PM		MOR	MorphoSys AG	1,620	-0.97	-0.60	-0.58	MorphoSys reports Q3 results [11/11/2021 1:32 AM]	10.82	-0.20 (-1.81%)	10.84	-0.18 (-1.63%)	10.76 - 30.75	105,714	60,000	12,354
MorphoSys reports Q3 results [11/11/2021 1:32 AM] MorphoSys Announces Departure of Roland Wandeler [Nov-09-21 04:20PM] MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results [Nov-11-21 12:30AM] MorphoSys AG (MOR) Q3 2021 Earnings Call Transcript [Nov-11-21 08:00PM]
28-07-2021	PM		MOR	MorphoSys AG	1,950	0.18	-0.53	-0.45	MorphoSys reports Q2 results [7/29/2021 1:49 AM]	13.98	0.20 (1.45%)	14.12	0.34 (2.47%)	13.21 - 34.99	99,604	150,000	451
MorphoSys reports Q2 results [7/29/2021 1:49 AM] MorphoSys AG Reports Second Quarter and First Half 2021 Results [Jul-29-21 12:45AM]
05-05-2021	AH	After the close (May 5)	MOR	MorphoSys AG	3,140	-0.38	-0.54	1.68	MorphoSys reports Q1 results [5/5/2021 4:43 PM]	22.09	0.56 (2.60%)	22.22	0.69 (3.20%)	21.26 - 35.73	23,289	30,000	1,000
MorphoSys AG Reports First Quarter 2021 Results [May-05-21 04:30PM] MorphoSys AG to Host Earnings Call [May-06-21 11:45AM] MorphoSys AG (MOR) Q1 2021 Earnings Call Transcript [May-06-21 08:00PM]
15-03-2021	AH		MOR	MorphoSys AG	3,360	-0.15	-0.57	-0.44	MorphoSys reports Q$ results [3/15/2021 5:41 PM]	22.64	-2.71 (-10.69%)	22.52	-2.83 (-11.16%)	18.21 - 35.73	488,442	130,423	15,162
MorphoSys reports Q$ results [3/15/2021 5:41 PM] MorphoSys AG Presents Results for Full Year 2020 [Mar-15-21 05:35PM] MorphoSys AG to Host Earnings Call [Mar-16-21 01:15PM]
05-08-2020	AH		MOR	MorphoSys AG	4,200	-0.45	-0.48	-0.05		32.30	-2.44 (-7.02%)	33.32	-1.42 (-4.09%)	18.21 - 37.96	119,070	146,029	840

06-05-2020	AH		MOR	MorphoSys AG	3,280	1.68	0.04	-0.20		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0